Lenvatinib: as the comparator
8 studies: what is tested is compared with it. Page 1 of 1. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.
- Study Comparing BGB-B2033 With Sorafenib or Lenvatinib in Advanced Hepatocellular CarcinomaRecruitingNCT07836530Phase 3Report a problem
- A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular CarcinomaRecruitingNCT07328009Phase 2Report a problem
- A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)RecruitingNCT06858813Phase 1Report a problem
- Sintilimab+Bevacizumab+TACE vs. Lenvatinib+TACE for Advanced HCCRecruitingNCT05985798Phase 3Report a problem
- CXD101 in Immunotherapy-related Liver CancerActive, not recruitingNCT05873244Phase 2Report a problem
- Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)Active, not recruitingNCT05822752Phase 2Report a problem
- Immunotherapy for Advanced Liver CancerSuspendedNCT05033522Phase 2/3Report a problem
- A Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular CarcinomaCompletedNCT04039607Phase 3Report a problem